Vanguard Capital Management
OSTX

Vanguard Capital Management’s OS Therapies Inc OSTX Stock Holding History

Vanguard Capital Management’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
777,651
+308,184
+66% +$517K ﹤0.01% 3507
2026
Q1 		$662K Buy
+469,467
New +$666K ﹤0.01% 3629

Other funds holding OSTX

CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Capital Management's OSTX Position: Q2 2026 in Review

Vanguard Capital Management increased its OS Therapies Inc (OSTX) stake by 66% in Q2 2026, buying an estimated $517K and bringing the position to 777,651 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3507.

Vanguard Capital Management first reported a position in OSTX in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Vanguard Capital Management held 777,651 shares of OS Therapies Inc worth $1.48M as of Q2 2026.
  • Vanguard Capital Management bought 308,184 OS Therapies Inc shares in Q2 2026, an estimated $517K.
  • OS Therapies Inc made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3507 holding.
  • Vanguard Capital Management first reported a position in OS Therapies Inc in Q1 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.